Search

iRhythm Technologies Inc

Open

SectorHealthcare

111.24 0.77

Overview

Share price change

24h

Current

Min

109.28

Max

116.05

Key metrics

By Trading Economics

Income

14M

-381K

Sales

25M

224M

EPS

0.58

Profit margin

-0.17

Employees

2,400

EBITDA

6.5M

2.9M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+58.13% upside

Dividends

By Acuity

Next Earnings

29 Oct 2026

Market Stats

By TradingEconomics

Market Cap

-458M

3.6B

Previous open

110.47

Previous close

111.24

News Sentiment

By Acuity

12%

88%

5 / 339 Healthcare

iRhythm Technologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

21 Sept 2026, 19:25 UTC

iRhythm Holdings, Inc. is advancing, continuing gains since Friday's close, despite earlier pulling back from a session high amid broader market strength.

18 Sept 2026, 19:16 UTC

iRhythm Holdings, Inc. shares fell sharply, remaining significantly below their 20-day moving average and near the lower end of their one-month trading range.

17 Sept 2026, 20:07 UTC

iRhythm Holdings, Inc. shares fell modestly, retracing from an early spike and settling near the lower end of its one-month trading range.

16 Sept 2026, 19:16 UTC

iRhythm Holdings, Inc. is trading modestly higher, with a cumulative return peaking at 0.79%, though still below its 20-day moving average.

15 Sept 2026, 22:31 UTC

iRhythm Holdings shows little change in after-hours trading, remaining significantly below its 20-day moving average amid broader performance weakness.

14 Sept 2026, 20:08 UTC

iRhythm Holdings, Inc. shares are higher today, recovering after five consecutive days of declines, though still below the 20-day moving average.

11 Sept 2026, 19:26 UTC

iRhythm Holdings, Inc. shares are lower today, continuing a trend with five consecutive daily declines amid steady inflation data influencing Federal Reserve policy.

10 Sept 2026, 20:03 UTC

News

iRhythm Holdings shares are trading lower amid an investigation into potential corporate wrongdoing by the company and certain officers, announced by Bronstein, Gewirtz & Grossman.

9 Sept 2026, 20:07 UTC

iRhythm Holdings, Inc. shares are lower amid a volatile session, trading significantly below their 20-day moving average after three consecutive daily declines.

8 Sept 2026, 20:07 UTC

News

iRhythm Holdings shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving company officers and directors.

2 Sept 2026, 20:08 UTC

iRhythm Holdings is trading roughly flat with no specific news. Broader market context includes weaker-than-expected private sector job growth in August.

1 Sept 2026, 20:09 UTC

iRhythm Holdings, Inc. shares are higher today, reflecting broader market gains. The stock has rebounded after pulling back earlier in the session.

31 Aug 2026, 20:07 UTC

iRhythm Holdings, Inc. shares are lower amid negative sentiment from Fed comments on potential interest rate hikes, following a decline since Friday's close.

28 Aug 2026, 20:02 UTC

iRhythm Holdings, Inc. shares are higher today, showing notable strength after four consecutive daily declines. No specific news was identified for the movement.

27 Aug 2026, 23:01 UTC

iRhythm Holdings is trading lower in after-market hours, extending a decline over the past four sessions. The stock is well below its 20-day moving average.

26 Aug 2026, 20:08 UTC

iRhythm Holdings is declining today, continuing a downward trend since Tuesday. Mixed market performance follows inflation data showing higher-than-expected consumer prices.

25 Aug 2026, 20:07 UTC

iRhythm Holdings, Inc. shares are lower today, reflecting the broader market decline since Monday's close. No specific news was identified to explain the drop.

24 Aug 2026, 19:46 UTC

iRhythm Holdings, Inc. shares are lower today amid rising oil prices and geopolitical tensions, though no specific company news has been identified.

21 Aug 2026, 19:46 UTC

News

iRhythm Technologies reported strong Q2 results and raised full-year guidance. The FDA clearance of the ZEUS platform is expected to save $100 million over five years.

20 Aug 2026, 19:46 UTC

iRhythm Technologies is trading higher, supported by positive economic indicators and maintaining strength above its 20-day moving average despite an earlier pullback.

19 Aug 2026, 20:02 UTC

iRhythm Technologies Inc shares are higher today, maintaining a strong performance above its 20-day moving average and near the upper end of its one-month range.

18 Aug 2026, 19:16 UTC

News

Wells Fargo lowered its price target on iRhythm Technologies to $168.00, while shares are trading lower since Monday's close amid routine intraday fluctuations.

17 Aug 2026, 20:01 UTC

iRhythm Technologies Inc shares are trading lower, reflecting broader market declines amid rising crude oil prices and inflationary pressures. No specific news was identified.

14 Aug 2026, 20:06 UTC

News

iRhythm Technologies reports second-quarter revenue of $224.17 million and updates full-year guidance. Shares are higher since Thursday's close despite earlier session declines.

13 Aug 2026, 20:06 UTC

News

iRhythm Technologies reported second-quarter revenue of $224.2 million, exceeding estimates, but shares are trading lower during Thursday's session.

12 Aug 2026, 19:56 UTC

iRhythm Technologies Inc. shares are higher Wednesday, reflecting positive market conditions despite earlier session pullbacks and recent downward pressure.

11 Aug 2026, 20:06 UTC

iRhythm Technologies shares are lower today, continuing a downward trend since Monday's close, despite stabilizing above the 20-day moving average.

10 Aug 2026, 19:41 UTC

News

iRhythm Technologies shares lower today despite Truist raising the price target to $168.00 and reporting Q2 sales of $224.2 million.

7 Aug 2026, 19:51 UTC

News

iRhythm Technologies is higher today, driven by strong earnings of $224.17 million and its acquisition of VitalConnect for $287.5 million.

6 Aug 2026, 23:02 UTC

News

iRhythm Technologies shares rise in after-market trading following strong Q2 results, $224.2 million in revenue, and an acquisition of VitalConnect for $287.5 million.

Peer Comparison

Price change

iRhythm Technologies Inc Forecast

Price Target

By TipRanks

58.13% upside

12 Months Forecast

Average 174.778 USD  58.13%

High 196 USD

Low 157 USD

Based on 12 Wall Street analysts offering 12 month price targets foriRhythm Technologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

12

Buy

0

Hold

0

Sell

Sentiment

By Acuity

5 / 339 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.